BETA
This is a BETA experience. You may opt-out by clicking here

More From Forbes

Edit Story

$1 Trillion, One Mission: Heal Medicine's Pain Points. The Forbes Healthcare Summit

This article is more than 6 years old.

Merck

Merck CEO Ken Frazier. Ian Read, who runs Pfizer, the world's largest drug company. Pharma billionaire Leonard Schleifer, the boss at  biotech Regeneron. The chief executives of Allergan, Express Scripts,  and Eli Lilly, the leaders of some of America's largest medical centers, and representatives from Siemens, CVS Health, and Bayer. They'll all gather in New York at the sixth annual Forbes Healthcare Summit on November 29 and 30. Perhaps you can attend, too?

Every year, our annual meeting brings together the biggest names in the medical business. This year, the public companies on stage alone will represent a combined market capitalization of more than $1 trillion. We'll have a special mission for the 24 hours of the summit: to identify the pain points that most trouble American healthcare, and to find some ways to relieve them.

United Therapeutics

The event will start on November 29 with an exclusive interview with the incoming chief executive of Novartis, Vas Narasimhan, focusing on the approval of the first cancer therapy that modifies patients' own cells to kill tumors. (The cost: $475,000.) We'll have plenty of Pharma news, including a bold proposal from Laurie Glimcher, the chief executive of the Dana-Farber Cancer Institute; an interview with Martine Rothblatt, one of the most captivating figures in the history of pharma, and a discussion of drug pricing that will include Alnylam Chief Executive John Maraganore. And, of course, our signature panel: The Pharma All-Stars, in which the CEOs of the world's biggest drug companies sit down for a frank discussion of just about everything.

We'll delve into other topics, too: executives from the insurance and hospital industry will try to define an elusive word, "value," that could be the Rosetta stone of our healthcare system. We'll take a deep look at how artificial intelligence is changing healthcare. And we'll try to look squarely at the opioid epidemic, the biggest public health crisis facing America today.

Novartis

The Forbes Healthcare Summit has never delivered a boring day. On this same stage, Michael J. Fox explained how to motivate scientists ("Dangle grant money"), Martin Shkreli voiced his one regret ("I would have raised prices higher") and Read and Schleifer got in a heated debate about the justification for drug prices. We don't intend on breaking that streak. Those interested can apply for an invitiation at this link.